Martin Eilers has received $25 million in funding for his research. In the foreground: employee Katrin Trunk, who will play a key role in the project. (Eilers/JMU, laterally extended with Firefly) (Image: Eilers/JMU)
Martin Eilers has received $25 million in funding for his research. In the foreground: employee Katrin Trunk, who will play a key role in the project. (Eilers/JMU, laterally extended with Firefly) (Image: Eilers/JMU) Cancer is one of the most common causes of death in children worldwide. A research team in which the University of Würzburg is involved wants to change this - and has now received substantial funding for its work. The team is co-led by Martin Eilers, Chair of Biochemistry and Molecular Biology at the University of Würzburg (JMU). "Our research project is called KOODAC," he explains. "That stands for 'Knocking-Out Oncogenic Drivers and Curing Childhood Cancer'".
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
